Roger Denton and Kristine Kraft of Schlichter, Bogard & Denton, LLP Report that the $100 Million NuvaRing® Settlement Will Go Forward
St. Louis, MO (PRWEB) June 04, 2014 -- Today we are pleased to announce that the global settlement for the NuvaRing litigation will go forward as planned since the 95% participation threshold has been reached. On February 7, 2014, United States District Court Judge Rodney W. Sippel approved a $100 Million settlement in the NuvaRing® Multidistrict Litigation In re: NuvaRing® Products Liability Litigation (MDL No. 1964, Case No. 08-md-1964). Under the terms of the settlement agreement, Merck had the right to abandon the deal (i.e., exercise “walk away rights”) if less than 95% of the eligible claimants refused to opt into the settlement program.
Roger Denton states, “The settlement was reached after more than four years of litigation, after reviewing millions of pages of documents produced by Organon, and the completion of more than 100 depositions - both in the United States and in Europe.” He further states, “Approximately 3,800 claimants will share in this settlement. The settlement program is a simplified and cost effective method that will bring the most compensation to the injured claimants and is fully endorsed by Judge Rodney Sippel, the MDL judge in St. Louis, Judge Brian Martinotti, the presiding mass tort judge in New Jersey, as well as the court-appointed mediator, retired federal Judge Wayne Andersen of Chicago.” Denton adds, “We are pleased that there is a high participation in the settlement program. This settlement is an outstanding result for this hard fought litigation and is in the best interests of all women included in the settlement who have alleged injuries associated with the use of NuvaRing®.”
Roger Denton and Kristine Kraft, both leaders in the national NuvaRing® litigation, represent numerous women and families who allege to have suffered serious injuries or even lost loved ones after using NuvaRing®. From their intense work as leaders in the national litigation, Denton and Kraft have been speaking out about the potential dangers of NuvaRing® and the lack of adequate warnings regarding the risks posed to women. Their efforts have garnered national attention for this important topic, including a January 2014 Vanity Fair article entitled "Danger in the Ring” and a January 2014 Huffington Post article entitled "Side Effects May Include Death.” Now, Denton and Kraft will appear on CNN’s "Anderson Cooper 360” in a 3-part series to further discuss the litigation, the global settlement reached in the MDL, the potential dangers of such birth control products, and the need for adequate warnings within the product labeling to appropriately inform women of the inherent risks.
About Schlichter, Bogard & Denton, LLP
Schlichter, Bogard & Denton, LLP is a unique law firm that has held numerous leadership positions in other national litigations involving dangerous pharmaceutical medications and unsafe medical devices, including but not limited to: In re: Pradaxa® (Dabigatran Etexilate) Products Liability (MDL 2385), In re: Yasmin® and Yaz® (Drospirenone) Marketing and Sales Practices and Products Liability Litigation (MDL 2100), In re: Gadolinium-Based Contrast Products Liability Litigation (MDL 1909), and In re: Ortho Evra® Products Liability Litigation (MDL 1742).
The Pharmaceuticals and Medical Litigation Department at Schlichter, Bogard & Denton aggressively represent clients who allege to have suffered injuries as a result of dangerous pharmaceutical medications and unsafe medical devices. The attorneys at Schlichter, Bogard & Denton, LLP who represent such victims include Roger Denton, Kristine Kraft, Beth Wilkins Flieger, Ashley Brittain Landers, and Tara Rocque. With hard work, creative thinking, and strong trial skills, we have earned an outstanding nationwide reputation by representing thousands of individuals who have suffered serious and life-threatening injuries, or even death.
If you or a loved has suffered injuries as a result of dangerous pharmaceutical medications or unsafe medical devices, please contact the attorneys at Schlichter, Bogard & Denton, LLP toll-free at 1-800-873-5297 for your confidential and free consultation.
Schlichter, Bogard & Denton, LLP also welcomes the opportunity to work with other attorneys on these types of cases. Schlichter, Bogard & Denton, LLP is available to either handle these cases or work as co-counsel, so other attorneys are invited to contact an attorney at the firm to explore this opportunity.
The choice of a lawyer is an important decision and should not be based solely on advertisements. The cases discussed do not predict outcomes in future cases. Past results afford no guarantee of future results and every case is different and must be judged on its own merits.
Kristine K. Kraft, Schlichter, Bogard & Denton, LLP, http://www.druginjuryinformation.com/, +1 (314) 621-6115, [email protected]
Share this article